Last reviewed · How we verify
Anlotinib combined with paclitaxel and carboplatin, phase I
Anlotinib combined with paclitaxel and carboplatin, phase I is a Small molecule drug developed by Chinese Academy of Medical Sciences. It is currently in Phase 1 development. Also known as: ATC I.
At a glance
| Generic name | Anlotinib combined with paclitaxel and carboplatin, phase I |
|---|---|
| Also known as | ATC I |
| Sponsor | Chinese Academy of Medical Sciences |
| Modality | Small molecule |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Phase 1/2a/3 Evaluation of Adding AL3818 to Standard Platinum-Based Chemotherapy in Subjects With Recurrent or Metastatic Endometrial, Ovarian, Fallopian, Primary Peritoneal or Cervical Carcinoma (AL3818-US-002) (PHASE3)
- Study of Anlotinib Plus Chemoradiotherapy in Patients With Locally Advanced NSCLC (PHASE1, PHASE2)
- Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Anlotinib combined with paclitaxel and carboplatin, phase I CI brief — competitive landscape report
- Anlotinib combined with paclitaxel and carboplatin, phase I updates RSS · CI watch RSS
- Chinese Academy of Medical Sciences portfolio CI
Frequently asked questions about Anlotinib combined with paclitaxel and carboplatin, phase I
What is Anlotinib combined with paclitaxel and carboplatin, phase I?
Anlotinib combined with paclitaxel and carboplatin, phase I is a Small molecule drug developed by Chinese Academy of Medical Sciences.
Who makes Anlotinib combined with paclitaxel and carboplatin, phase I?
Anlotinib combined with paclitaxel and carboplatin, phase I is developed by Chinese Academy of Medical Sciences (see full Chinese Academy of Medical Sciences pipeline at /company/chinese-academy-of-medical-sciences).
Is Anlotinib combined with paclitaxel and carboplatin, phase I also known as anything else?
Anlotinib combined with paclitaxel and carboplatin, phase I is also known as ATC I.
What development phase is Anlotinib combined with paclitaxel and carboplatin, phase I in?
Anlotinib combined with paclitaxel and carboplatin, phase I is in Phase 1.
Related
- Manufacturer: Chinese Academy of Medical Sciences — full pipeline
- Also known as: ATC I
- Compare: Anlotinib combined with paclitaxel and carboplatin, phase I vs similar drugs
- Pricing: Anlotinib combined with paclitaxel and carboplatin, phase I cost, discount & access